Live Science is supported by its audience. When you purchase through links on our site, we may earn an affiliate commission. Learn more
By Rachael Rettner published 9 September 21
It's an extremely rare complication.
A man's persistently runny nose following a COVID-1
LOS ANGELES--(BUSINESS WIRE)-- BiologyWorks™, Inc., a digital healthcare platform company, today announced that a substantive clinical trial of its handheld, reusable molecular test for COVID-19 matched 99.1% accuracy to laboratory RT-PCR tests.
This press release features multimedia.
Please enter a search term.
Please enter a search term.
CLEVELAND HEIGHTS, Ohio (WJW) – If you live in Cleveland Heights, you probably are very familiar with Heights Cleaners. At the end of the month, however, after 65 years, the 98-year-old owner is going to retire.
E
Example video title will go here for this video
ATLANTA — People continue to wait in line for tests while trying to find available at-home tests in this latest COVID-19 case surge. But, just as people were getting used to the idea of swabbing their noses (sometimes multiple times a day
Nasal swabs are the standard way to test for COVID-19 - but Omicron may have changed the game. Image: Andrey_Popov/Shutterstock
To paraphrase Mrs Gump: COVID-19 is like a box of chocolates. You never know what you're gonna get. For some people, it can be a debilitating disease that last
Objective: To compare the concordance and acceptability of saliva testing with standard‐of‐care oropharyngeal and bilateral deep nasal swab testing for severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) in children and in general practice.
Design: Prospective multicen
With a focus on Global Medical Swab For Covid-19 Test Market and general market expansion and trends for 2022-2030, by Marketreports.info reports on the main elements and current market trends. There is a projected income for Medical Swab For Covid-19 Test in the period 2022-2030 (2022 is used
NEW YORK – Becton Dickinson has received 510(k) clearance from the US Food and Drug Administration for the MX molecular diagnostics module along with a triplex assay for chlamydia, gonorrhea, and trichomonas. The test and instrument, which is part of the modular BD Cor system, are now commer
ABBOTT PARK , Ill. , May 4, 2022 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received FDA clearance for its Alinity™ m STI Assay. The test simultaneously detects and differentiates four common sexually transmitted infections (STIs). STIs, when left untreated, can lead to seve